For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| MRE, Patency Capsule (if Needed), CE, and IC | Single-arm study, which includes MRE procedure, Patency Capsule Procedure (if needed), PillCam Crohn's Capsule Endoscopy Procedure and Ileocolonoscopy procedure. Capsule Endoscopy: At baseline subject will under the PillCam Crohn's Capsule Procedure | 0 | None | 7 | 119 | 11 | 119 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Abdominal pain | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | ISO 14155:2011 | View |
| Crohn's Disease | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | ISO 14155:2011 | View |
| Complication of device removal | NON_SYSTEMATIC_ASSESSMENT | General disorders | ISO 14155:2011 | View |
| Clostridium difficile infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | ISO 14155:2011 | View |
| Serum sickness | NON_SYSTEMATIC_ASSESSMENT | Immune system disorders | ISO 14155:2011 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Abdominal pain | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | ISO 14155:2011 | View |
| Constipation | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | ISO 14155:2011 | View |
| Haematochezia | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | ISO 14155:2011 | View |
| Haemorrhoids | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | ISO 14155:2011 | View |
| Infusion site extravasation | NON_SYSTEMATIC_ASSESSMENT | General disorders | ISO 14155:2011 | View |
| Oesophageal candidiasis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | ISO 14155:2011 | View |
| Staphylococcal skin infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | ISO 14155:2011 | View |
| Infusion related reaction | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | ISO 14155:2011 | View |
| Post procedural complication | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | ISO 14155:2011 | View |
| Haemoglobin decreased | NON_SYSTEMATIC_ASSESSMENT | Investigations | ISO 14155:2011 | View |
| Arthralgia | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | ISO 14155:2011 | View |
| Myalgia | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | ISO 14155:2011 | View |
| Emotional distress | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | ISO 14155:2011 | View |
| Fatigue | NON_SYSTEMATIC_ASSESSMENT | General disorders | ISO 14155:2011 | View |